Mysimba 8 mg/90 mg prolonged-release tablets

Company:
Consilient Health Ltd
Status:
Updated
Legal Category:
Product subject to medical prescription which may not be renewed (A)
Active Ingredient(s):
Bupropion HydrochlorideNaltrexone Hydrochloride
This medicinal product is subject to additional monitoring.
*Additional information is available within the SPC or upon request to the company

Licence number

Strength

ATC code

Dosage form

EU/1/14/988/001

8mg/90 milligram(s)

R06AX,A08AA62

Prolonged-release tablet